Conditions · Diabetes complications
Diabetic nephropathy / diabetic kidney disease
Diabetic kidney disease is kidney damage from long-term diabetes, identified through regular testing well before symptoms appear — and it's the leading cause of chronic kidney disease in India, contributing to nearly half the country's dialysis cases. Two simple tests, one blood and one urine, combine to show your specific risk category, which shapes how closely you're monitored and how your treatment is chosen.
Your kidney health monitoring pathway
Annual Screening
A blood test (eGFR) and a urine test (albumin-to-creatinine ratio) for everyone with diabetes.
Determining Your Risk Category
Combining both results on a standardized risk grid, rather than judging either test alone.
Setting Your Monitoring Frequency
Higher-risk categories are checked more often than once a year.
Blood Pressure and Glucose Targets
Individualized targets specifically chosen to protect kidney function.
Kidney-Protective Medication Where Indicated
Medicines shown to slow progression, added based on your specific findings.
Specialist Coordination
Nephrology involvement for more advanced stages, coordinated through partner facilities.
Symptoms
- Often no symptoms in early stages — this is why regular testing matters
- Swelling in the legs, ankles, or feet in later stages
- Fatigue
- Foamy urine (a possible sign of protein in the urine)
Causes & risk factors
- Long-duration or poorly-controlled diabetes
- High blood pressure
- A family history of kidney disease
Diabetic nephropathy is the single leading cause of chronic kidney disease in India, responsible for roughly 31% of cases, and diabetes is the primary cause of kidney failure in an estimated 45% of India's dialysis patients. Overall CKD prevalence in India (about 13.2%) is comparable to the global rate, but among people specifically living with type 2 diabetes, over 40% are affected.
Understanding your risk category
Kidney health is assessed with two tests together, not either one alone — combining them gives a far more accurate picture of your risk than either result by itself.
- This is a simplified, patient-friendly version of the standard international (KDIGO) risk grid, which uses more detailed categories in clinical practice
- Your specific category — not just one number — determines how often you're tested and how actively your treatment is adjusted
| Kidney function (eGFR) | Normal urine protein | Moderately increased protein | Severely increased protein |
|---|---|---|---|
| Normal or high | Low risk | Moderately increased risk | High risk |
| Mildly to moderately reduced | Moderately increased risk | High risk | Very high risk |
| Severely reduced | High risk | Very high risk | Very high risk |
The kidneys
Long-term high blood sugar can gradually damage the kidneys' filtering ability
Blood and urine tests
A blood test (eGFR) and a urine test (albumin-to-creatinine ratio) together define your risk category
Cardiovascular connection
Kidney risk and cardiovascular risk rise together, which is why both are monitored as connected, not separate
How we screen and stage your kidney health
Both tests are simple, routine, and done well before any symptoms would appear.
- eGFR (estimated glomerular filtration rate) — a blood test estimating how well your kidneys are filtering
- UACR (urine albumin-to-creatinine ratio) — a urine test checking for protein leaking into the urine, often the earliest detectable sign
- Both are recommended at least annually for everyone with diabetes, more often if your risk category is higher
Kidney-protective medications
Beyond glucose and blood pressure control generally, specific medicines have been shown to directly slow kidney disease progression.
- Molecule names are used here first; specific brand selection is discussed individually and noted for recognition only, not as an endorsement of any manufacturer
| Medicine class | Example molecule | Role |
|---|---|---|
| SGLT2 inhibitors | Such as dapagliflozin or empagliflozin | First-line to reduce kidney disease progression and cardiovascular risk, recommended regardless of CKD severity down to an eGFR of about 20 |
| ACE inhibitors / ARBs | Such as ramipril or telmisartan | Foundational for reducing protein in the urine and controlling blood pressure |
| Finerenone | A newer, non-steroidal medicine class | Added alongside an SGLT2 inhibitor, or used as an alternative if one isn't tolerated; in specific situations (higher urine protein levels with preserved kidney function), it may be started at the same time as an SGLT2 inhibitor |
Blood pressure and glucose targets
Both are managed with kidney protection specifically in mind, not just general diabetes control — see our hypertension page for the current blood pressure target (below 130/80, with below 120 systolic encouraged for higher kidney risk where safely achievable). Glucose targets are similarly individualized, balancing kidney protection against your overall health and hypoglycemia risk.
When specialist care is coordinated
For more advanced stages, care is coordinated with nephrology and partner facilities for specialized testing or treatment beyond what's managed here.
It's worth being clear and realistic: early detection and consistent treatment substantially reduce the risk of progression, but don't eliminate it entirely for every patient — which is exactly why ongoing monitoring, not a one-time test, is the standard of care.
How it’s diagnosed
Diagnosis and staging rely on regular blood tests (estimated glomerular filtration rate) and urine testing (albumin-to-creatinine ratio), combined into a risk category per KDIGO/ADA guidance.
How it’s treated
Management focuses on blood pressure and glucose control, kidney-protective medications (including SGLT2 inhibitors, ACE inhibitors/ARBs, and finerenone where appropriate) shown to slow disease progression, and regular monitoring. Advanced kidney disease is coordinated with nephrology and partner facilities.
When to seek care
- New or worsening swelling in the legs or feet
- A significant, unexplained drop in urine output
- Symptoms of very high blood pressure
- Persistent nausea, vomiting, or loss of appetite
FAQ
Can diabetic kidney disease be caught early?
Yes — this is exactly what regular kidney function and urine testing are for, since early-stage kidney disease usually has no symptoms.
What is eGFR?
Estimated glomerular filtration rate — a blood test result estimating how well your kidneys are filtering. It's one of the two main measures used to assess kidney health.
What does UACR or albuminuria mean?
UACR (urine albumin-to-creatinine ratio) measures protein leaking into your urine — often the earliest detectable sign of kidney involvement, sometimes appearing before eGFR changes.
What does my risk category actually mean for me?
It combines your eGFR and UACR results into an overall risk level that determines how often you're tested and how actively treatment is adjusted — it's more informative than either test viewed alone.
How often do I need kidney testing?
At least annually if you have diabetes, and more frequently if your risk category is higher — your care team will set a specific schedule based on your results.
Which medicines protect the kidneys specifically?
SGLT2 inhibitors are first-line regardless of CKD severity, ACE inhibitors or ARBs are foundational for reducing urine protein and blood pressure, and finerenone may be added or used as an alternative in specific situations.
Are SGLT2 inhibitors safe?
They're a well-established, guideline-recommended treatment class for kidney protection in diabetes, with an extensive evidence base — any specific concerns for your situation are discussed individually.
What is finerenone?
A newer, non-steroidal medicine that can be added alongside an SGLT2 inhibitor, or used as an alternative if one isn't tolerated, to further reduce kidney disease progression in specific situations.
Can kidney damage from diabetes be reversed?
Existing damage isn't always fully reversible, but early detection and consistent treatment can substantially slow or, for some patients, stabilize progression — which is why regular monitoring matters even without symptoms.
Does blood pressure control matter as much as glucose control?
Yes — both are managed with kidney protection specifically in mind, and blood pressure targets for kidney protection are often stricter than general targets.
How common is diabetic kidney disease in India?
Very common — diabetic nephropathy is the leading cause of chronic kidney disease in India, responsible for roughly 31% of CKD cases, and diabetes is the primary cause of kidney failure in an estimated 45% of India's dialysis patients.
When do I need to see a kidney specialist?
For more advanced stages or specific findings that need specialized testing or treatment — your care team coordinates this with nephrology and partner facilities when it's appropriate for your situation.
Does diabetic kidney disease always lead to dialysis?
No — most people with diabetic kidney disease don't reach that stage, particularly with early detection and consistent treatment. Regular monitoring is specifically aimed at catching and slowing progression well before that point.
What diet changes help protect the kidneys?
This is individualized to your stage and test results — general diabetes nutrition guidance applies, with specific adjustments (such as protein or sodium intake) discussed directly if your kidney function or risk category calls for them.
Medical disclaimer: Content on this page is for general education and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary between patients. Boston Diabetes Center is outpatient / day-care specialty centre with an on-site diagnostic lab and pharmacy — no inpatient beds; imaging and inpatient care are coordinated through partner facilities.